Harold Bernstein, President, R&D & CMO at Maze Therapeutics, Inc. (MAZE), sold 14,609 shares at $29.86 ($437K) on 2026-07-01, disclosed to the SEC on 2026-07-02.
Scheduled sale ($437k) by President, R&D & CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.86 | 13,409 | $400K | 91.7% |
| 2 | $30.34 | 1,200 | $36K | 8.3% |
| Total | $29.90 avg | 14,609 | $437K | 100% |
| Filing → |
| MAZE | SELL | 2026-09-04 | $270K | — | Filing → |
| MAZE | SELL | 2026-09-03 | $426K | — | Filing → |
| MAZE | SELL | 2026-08-14 | $446K | — | Filing → |